Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2007;101:295-303
Published online before print June 21, 2007, doi: 10.1161/CIRCRESAHA.107.148676
Free Article
This Article
Free upon publication Free Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
101/3/295    most recent
CIRCRESAHA.107.148676v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Leong-Poi, H.
Right arrow Articles by Lindner, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Leong-Poi, H.
Right arrow Articles by Lindner, J. R.
Related Collections
Right arrow Angiogenesis
Right arrow Peripheral vascular disease
Right arrow Gene therapy
Right arrowRelated Article
(Circulation Research. 2007;101:295.)
© 2007 American Heart Association, Inc.


Integrative Physiology

Therapeutic Arteriogenesis by Ultrasound-Mediated VEGF165 Plasmid Gene Delivery to Chronically Ischemic Skeletal Muscle

Howard Leong-Poi, Michael A. Kuliszewski, Michael Lekas, Matthew Sibbald, Krystyna Teichert-Kuliszewska, Alexander L. Klibanov, Duncan J. Stewart, Jonathan R. Lindner

From the Division of Cardiology (H.L.P., M.A.K., M.L., M.S., K.T.K., D.J.S.), Keenan Research Centre in the Li Ka Shing Knowledge Institute, St Michael’s Hospital, Toronto, Ontario, Canada; the Cardiovascular Division (J.R.L.), Oregon Health and Science University, Portland; and the University of Virginia (A.L.K.), Charlottesville.

Correspondence to Howard Leong-Poi, MD, 7-052 Bond Wing, St Michael’s Hospital, 30 Bond Street, Toronto, Ontario, Canada M5B 1W8. E-mail leong-poih{at}smh.toronto.on.ca

Current methods of gene delivery for therapeutic angiogenesis are invasive, requiring either intraarterial or intramuscular administration. A noninvasive method of gene delivery has been developed using ultrasound-mediated destruction of intravenously administered DNA-bearing carrier microbubbles during their microcirculatory transit. Here we show that chronic ischemia could be markedly improved by ultrasound-mediated destruction of microbubbles bearing vascular endothelial growth factor-165 (VEGF165) plasmid DNA. Using a model of severe chronic hindlimb ischemia in rats, we demonstrated that ultrasound mediated VEGF165/green fluorescent protein (GFP) plasmid delivery resulted in a significant improvement in microvascular blood flow by contrast-enhanced ultrasound, and an increased vessel density by fluorescent microangiography, with minimal changes in control groups. The improvement in tissue perfusion was attributed predominantly to increases in noncapillary blood volume or arteriogenesis, with perfusion peaking at 14 days after delivery, followed by a partial regression of neovascularization at 6 weeks. Transfection was localized predominantly to the vascular endothelium of arterioles in treated ischemic muscle. RT-PCR confirmed the presence of VEGF165/GFP mRNA within treated ischemic muscle, being highest at day 3 postdelivery, and subsequently decreasing, becoming almost undetectable by 6 weeks. We found a modulation of endogenous growth factor expression in VEGF-treated ischemic muscle, consistent with a biologic effect of ultrasound mediated gene delivery. The results of our study demonstrate the utility of ultrasonic destruction of plasmid-bearing microbubbles to induce therapeutic arteriogenesis in the setting of severe chronic ischemia.


Key Words: angiogenesis • gene therapy • contrast ultrasound • peripheral vascular disease • chronic ischemia


Related Article:

New Targeted Angiogenic Strategy: Bursting Bubbles
Tomosaburo Takahashi and Hiroaki Matsubara
Circ. Res. 2007 101: 232-233. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
J. Kobulnik, M. A. Kuliszewski, D. J. Stewart, J. R. Lindner, and H. Leong-Poi
Comparison of gene delivery techniques for therapeutic angiogenesis ultrasound-mediated destruction of carrier microbubbles versus direct intramuscular injection.
J. Am. Coll. Cardiol., October 27, 2009; 54(18): 1735 - 1742.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
R. Gupta, J. Tongers, and D. W. Losordo
Human Studies of Angiogenic Gene Therapy
Circ. Res., October 9, 2009; 105(8): 724 - 736.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll Cardiol ImgHome page
F. S. Villanueva
Ultrasound Mediated Destruction of DNA-Loaded Microbubbles for Enhancement of Cell-Based Therapies: New Promise Amidst a Confluence of Uncertainties?
J. Am. Coll. Cardiol. Img., July 1, 2009; 2(7): 880 - 882.
[Full Text] [PDF]


Home page
Circ. Res.Home page
B. D.M. Meijering, L. J.M. Juffermans, A. van Wamel, R. H. Henning, I. S. Zuhorn, M. Emmer, A. M.G. Versteilen, W. J. Paulus, W. H. van Gilst, K. Kooiman, et al.
Ultrasound and Microbubble-Targeted Delivery of Macromolecules Is Regulated by Induction of Endocytosis and Pore Formation
Circ. Res., March 13, 2009; 104(5): 679 - 687.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
M. C. van Oostrom, O. van Oostrom, P. H. A. Quax, M. C. Verhaar, and I. E. Hoefer
Insights into mechanisms behind arteriogenesis: what does the future hold?
J. Leukoc. Biol., December 1, 2008; 84(6): 1379 - 1391.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
B. Modarai, J. Humphries, J.A. Gossage, M. Waltham, K.G. Burnand, G.S. Kanaganayagam, A. Afuwape, E. Paleolog, A. Smith, and A. Wadoodi
Adenovirus-Mediated VEGF Gene Therapy Enhances Venous Thrombus Recanalization and Resolution
Arterioscler Thromb Vasc Biol, October 1, 2008; 28(10): 1753 - 1759.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. C. Chappell, J. Song, A. L. Klibanov, and R. J. Price
Ultrasonic Microbubble Destruction Stimulates Therapeutic Arteriogenesis Via the CD18-Dependent Recruitment of Bone Marrow-Derived Cells
Arterioscler Thromb Vasc Biol, June 1, 2008; 28(6): 1117 - 1122.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll Cardiol ImgHome page
T. T. Rissanen, P. Korpisalo, H. Karvinen, T. Liimatainen, S. Laidinen, O. H. Grohn, and S. Yla-Herttuala
High-resolution ultrasound perfusion imaging of therapeutic angiogenesis.
J. Am. Coll. Cardiol. Img., January 1, 2008; 1(1): 83 - 91.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
T. Takahashi and H. Matsubara
New Targeted Angiogenic Strategy: Bursting Bubbles
Circ. Res., August 3, 2007; 101(3): 232 - 233.
[Full Text] [PDF]